Twenty-four hour hormone profiles of TSH, free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 4, 2007, Pages 261-267

  Saravanan, P ^a   Siddique, H ^b   Simmons, D J ^a   Greenwood, R ^b   Dayan, C M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

24 hour profile; Diurnal variation; Hypothyroidism; Thyroxine; Triiodothyronine

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PLACEBOS; PULSE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 34248582561     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973071     Document Type: Article

References (32)

1. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005; 90: 2666-2674
2. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001; 134: 561-568
3. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89
4. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002a; 137: 904-914
5. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 2002b; 87: 968-974
6. Blanchard KR. Dosage recommendations for combination regimen of thyroxine and 3,5,3′-triiodothyronine. J Clin Endocrinol Metab 2004; 89: 1486-1487
7. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange AJ Jr. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 2002; 18: 129-133
8. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340: 424-429
9. Busnardo B, Girelli ME, Bui F, Zanatta GP, Cimitan M. Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment. J Endocrinol Invest 1980; 3: 353-356
10. Clyde PW, Harari AE, Getka EJ, Shakir KMM. Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism: A Randomized Controlled Trial. JAMA: The Journal of the American Medical Association 2003; 290: 2952-2958
11. Cooper DS: Combined T4 and T3 therapy - back to the drawing board. JAMA 2003; 290: 3002-3004
12. Escobar-Morreale HF, Obregon MJ, Escobar dR, Morreale dE. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest 1995; 96: 2828-2838
13. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005; 142; 412-424
14. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994; 130: 350-356
15. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma Cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) 1981; 14: 451-458
16. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14: 271-275
17. Saberi M, Utiger RD. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab 1974; 39: 923-927
18. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 2002; 57: 577-585
19. Saravanan P, Dayan CM. Understanding thyroid hormone action and the effects of thyroid hormone replacement - just the beginning not the end. Hot Thyroidology 2004, October: No 1 (free access at www.hotthyroidology.com)
20. Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90: 805-812
21. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88: 4551-4555
22. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004; 10: 638-642 Epub 2004 May 16
23. Scott RS, Donald RA, Espiner EA. Plasma ACTH and Cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978; 9: 571-576
24. Sheppard MC, Holder R, Franklyn JA. Levothyroxine treatment and occurrence of fracture of the hip. Arch Intern Med 2002; 162: 338-343
25. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sanger E, Engel G, Hamm AO, Nauck M, Meng W. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 2004; 60: 750-757
26. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996; 81: 4278-4289
27. Walsh JP. Dissatisfaction with thyroxine therapy - could the patients be right? Curr Opin Pharmacol 2002; 2: 717-722
28. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwat SS, Chew GT, Bhagat MC, Cussons AJ. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003; 88: 4543-4550
29. Walsh JP, Stuckey BG. What is the optimal treatment for hypothyroidism? Med J Aust 2001; 174: 141-143
30. Wartofsky L. Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid 2004; 14: 247-248
31. Weeke J, Gundersen HJ. Circadian and 30 minutes variations in serum TSH and thyroid hormones in normal subjects. Acta Endocrinol (Copenh) 1978; 89: 659-672
32. Woliner K Combined T4/T3 Therapy: Placebo or Tomato? On line article 2003; (assessed at www.thyroidabout.com on 20.10.2006)